Novak Djokovic is majority shareholder in biotech firm making COVID treatment
Embattled Serbian tennis star, Novak Djokovic who was recently deported from Australia has been discovered to be a co-founder and the majority shareholder in a firm developing a Covid-19 treatment.
Recall that days ago, Djokovic who was sent out of Australia after a row with authorities on his insistence on not getting vaccinated, owns an 80% share in the Danish biotech company, QuantBioRes.
The company’s chief executive, Ivan Loncarevic said;
‘He is one of the founders of my company we founded in June 2020.’
According to the Danish business register, Djokovic and his wife, Jelena, are the majority shareholders at the firm, which employs around 20 staff in Denmark, Slovenia, Australia and Britain.
Mr Loncarevic explained that the company are working on a treatment not a vaccine, and added:
‘We aim to develop a new technology to fight viruses and resistant bacteria and we decided to use Covid as a showcase.
‘If we succeed with Covid, we will succeed with other viruses.’
Described as a ‘talisman of anti-vaccination sentiment’ by Australia’s immigration minister, Djokovic also sparked controversy in summer 2020 when he hosted a charity tennis tournament with little social distancing that led to a Covid outbreak.
He left Australia on Sunday January 16 after a last-gasp court bid to stay failed, meaning he missed the opening Grand Slam of the year, where he was targeting a record 21st major title.
The tennis star also faces the prospect of being unable to defend his French Open title after the government there ruled that all athletes will have to be jabbed to compete in sporting events.